Management of Stage III Non-Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update

Management of Stage III NSCLC Guideline Expert Panel

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

ASCO Rapid Recommendation Updates highlight revisions to select ASCO guideline recommendations as a response to the emergence of new and practice-changing data. The rapid updates are supported by an evidence review and follow the guideline development processes outlined in the ASCO Guideline Methodology Manual. The goal of these articles is to disseminate updated recommendations, in a timely manner, to better inform health practitioners and the public on the best available cancer care options. Guidelines and updates are not intended to substitute for independent professional judgment of the treating provider and do not account for individual variation among patients. See appendix for disclaimers and other important information (Appendix 1 and Appendix 2, online only).

Original languageEnglish
Pages (from-to)3058-3060
Number of pages3
JournalJournal of Clinical Oncology
Volume42
Issue number25
DOIs
StatePublished - Sep 1 2024

Fingerprint

Dive into the research topics of 'Management of Stage III Non-Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update'. Together they form a unique fingerprint.

Cite this